GENE ONLINE|News &
Opinion
Blog

2019-12-30| Technology

‘CRISPR Babies’ Researchers Given Prison Sentence by Chinese Court

by Rajaneesh K. Gopinath
Share To

By Rajaneesh K. Gopinath, Ph.D.

In November 2018, Chinese biophysicist He Jiankui shocked the world by announcing his creation of the “CRISPR babies” at an International Summit causing much furor across the globe. The researchers claimed that the intention of the study was to immunize the twin baby sisters Lulu and Nana against HIV by modifying the CCR5 gene in the embryo. However, a recent examination of the unpublished manuscripts by the MIT Technology Review involving four experts have found that the claims made by He and his team are not supported by data.

According to a report from Xinhua news agency, on December 30th, the Shenzhen Nanshan District People’s Court in South China has punished He and his coworkers Zhang Renli and Qin Jinzhou. The defendants were found to be guilty of jointly carrying out human embryo gene editing and reproductive medical activities for reproductive purposes. The court has found that the trio conspired since 2016 and has deliberately violated scientific regulations and crossed ethical boundaries.

While He Jiankui is sentenced to a three-year prison sentence including a fine of 3 million Chinese yuan (US$430,000), the others are given lesser sentences. Zhang Renli was sentenced to two years with a 1 million yuan fine and Qin Jinzhou received an 18-month sentence with a 500,000 yuan fine. All defendants pleaded guilty to the offense.

 

References
  1. https://mp.weixin.qq.com/s/5utIos-cXONVUh7Qn0Za9w
  2. https://www.technologyreview.com/s/614764/chinas-crispr-babies-read-exclusive-excerpts-he-jiankui-paper/

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
R&D
Study Finds High Viral Loads Fuel Higher HIV Recombination Rates
2024-01-12
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top